FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Maloney

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Rainer Storb; Barry E Storer; Mohamed L Sorror; Boglarka Gyurkocza; David G Maloney; Paul J Martin; Marco Mielcarek; Brenda M Sandmaier
Allogeneic Hematopoietic Cell Transplantation following Minimal Intensity Conditioning: Predicting Acute Graft-versus-Host Disease and Graft-versus-Tumor Effects.
Oliver W Press; Lisa M Rimsza; Catherine Spier; Joseph M Unger; Rita M Braziel; Bruce D Cheson; Myron S Czuczman; Shaker R Dakhil; Jonathan W Friedberg; Ajay K Gopal; Mark S Kaminski; Michael LeBlanc; David G Maloney; Thomas P Miller; Richard I Fisher
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016.
David G Maloney
Anti-CD20 antibody therapy for B-cell lymphomas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Maloney (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rainer Storb; Barry E Storer; Mohamed L Sorror; Boglarka Gyurkocza; David G Maloney; Paul J Martin; Marco Mielcarek; Brenda M Sandmaier
Allogeneic Hematopoietic Cell Transplantation following Minimal Intensity Conditioning: Predicting Acute Graft-versus-Host Disease and Graft-versus-Tumor Effects.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(5):792-8.
2013: Oliver W Press; Lisa M Rimsza; Catherine Spier; Joseph M Unger; Rita M Braziel; Bruce D Cheson; Myron S Czuczman; Shaker R Dakhil; Jonathan W Friedberg; Ajay K Gopal; Mark S Kaminski; Michael LeBlanc; David G Maloney; Thomas P Miller; Richard I Fisher
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(3):314-20.
2012: David G Maloney
Anti-CD20 antibody therapy for B-cell lymphomas.
The New England journal of medicine 2012;366(21):2008-16.
2012: Brian G Till; Jinjuan Wang; Xiaojun Qian; Andrew Raubitschek; Stanley R Riddell; Lihua E Budde; Stephen J Forman; Ajay K Gopal; Philip D Greenberg; Michael C Jensen; Yukang Lin; CG Lindgren; David G Maloney; John M Pagel; Oliver W Press
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results.
Blood 2012;119(17):3940-50.
2012: Ron Ram; Marcello Rotta; Brenda M Sandmaier; Bee K Chua; Mary E D Flowers; David G Maloney; Paul J Martin; Marco Mielcarek; Barry Storer; Rainer Storb
Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(3):414-22.
2011: Hirohisa Nakamae; Brenda M Sandmaier; Rainer Storb; Barry Storer; Lawrence Corey; Chris Davis; David G Maloney; Michael Boeckh
Cytopenias after day 28 in allogeneic hematopoietic cell transplantation: impact of recipient/donor factors, transplant conditions and myelotoxic drugs.
Haematologica 2011;96(12):1838-45.
2011: Mohamed L Sorror; Barry E Storer; Lars Vindeløv; Andrew Yeager; Edward Agura; Wolfgang Bethge; Karl G Blume; Benedetto Bruno; Thomas R Chauncey; Georg N Franke; George E Georges; Parameswaran Hari; Kai Hübel; Amelia Langston; Ginna G Laport; David G Maloney; Michael B Maris; Richard T Maziarz; Peter A McSweeney; Marco Mielcarek; Dietger Niederwieser; Finn Bo Petersen; Michael Allen Pulsipher; Firoozeh Sahebi; Brenda M Sandmaier; Rainer Storb
Long-term outcomes among older patients following nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation for advanced hematologic malignancies.
JAMA : the journal of the American Medical Association 2011;306(17):1874-83.
2011: Andrew R Rezvani; Brenda M Sandmaier; Rainer F Storb; Barry E Storer; David G Maloney; Paul J Martin; Marco Mielcarek; George B McDonald
Decreased serum albumin as a biomarker for severe acute graft-versus-host disease after reduced-intensity allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(11):1594-601.
2011: Ron Ram; Brenda M Sandmaier; Andrei R Shustov; Rainer F Storb; David G Maloney; Paul O'Donnell; John M Pagel; Stephen H Petersdorf; Oliver W Press; Mary E D Flowers; Theodore A Gooley; Ajay K Gopal
Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(10):1537-45.
2011: Ron Ram; Brenda M Sandmaier; Rainer Storb; Barry Storer; Ann Woolfrey; Thoralf Lange; Amelia A Langston; Ginna G Laport; David G Maloney; Michael B Maris; Thomas R Chauncey; Mary E D Flowers; George E Georges
Non-myeloablative conditioning with allogeneic hematopoietic cell transplantation for the treatment of high-risk acute lymphoblastic leukemia.
Haematologica 2011;96(8):1113-20.
2011: Ajay K Gopal; Katherine A Guthrie; David G Maloney; Manuela C Matesan; George Oliveira; John M Pagel; Joseph G Rajendran; Rainer F Storb; Oliver W Press
⁹⁰Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma.
Blood 2011;118(4):1132-9.
2011: Larry D Anderson; Carolina Berger; Danielle R Cook; David G Maloney; Tori N Yamamoto; Stanley R Riddell
Identification of MAGE-C1 (CT-7) epitopes for T-cell therapy of multiple myeloma.
Cancer immunology, immunotherapy : CII 2011;60(7):985-97.
2011: Andrew R Rezvani; David G Maloney
Rituximab resistance.
Best practice & research. Clinical haematology 2011;24(2):203-16.
2010: Michael Hudecek; Thomas M Schmitt; Sivasubramanian Baskar; Maria Teresa Lupo-Stanghellini; Tetsuya Nishida; Tori N Yamamoto; Marie Bleakley; Cameron J Turtle; Wen-Chung Chang; Harvey A Greisman; Brent Wood; David G Maloney; Michael C Jensen; Christoph Rader; Stanley R Riddell
The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor.
Blood 2010;116(22):4532-41.
2010: Marcello Rotta; Barry E Storer; Rainer Storb; Paul J Martin; Mary E D Flowers; Miwa S Vernon; Amanda Peffer; David G Maloney; H Joachim Deeg; Brenda M Sandmaier; Frederick R Appelbaum; Marco Mielcarek
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(10):1463-6.
2010: Andrei R Shustov; Theodore A Gooley; Brenda M Sandmaier; Judith A Shizuru; Mohamed L Sorror; Firoozeh Sahebi; Peter McSweeney; Dietger Niederwieser; Benedetto Bruno; Rainer Storb; David G Maloney
Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.
British journal of haematology 2010;150(2):170-8.
2010: Boglarka Gyurkocza; Rainer Storb; Barry E Storer; Thomas R Chauncey; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Christopher N Bredeson; Richard T Maziarz; Benedetto Bruno; Finn B Petersen; Michael B Maris; Edward Agura; Andrew Yeager; Wolfgang A Bethge; Firoozeh Sahebi; Frederick R Appelbaum; David G Maloney; Brenda M Sandmaier
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2859-67.
2010: Zejing Wang; Mohamed L Sorror; Wendy Leisenring; Gary Schoch; David G Maloney; Brenda M Sandmaier; Rainer Storb
The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.
British journal of haematology 2010;149(1):101-10.
2010: Hirohisa Nakamae; Barry E Storer; Rainer Storb; Jan Storek; Thomas R Chauncey; Michael Allen Pulsipher; Finn B Petersen; James C Wade; Michael B Maris; Benedetto Bruno; Jens Panse; Effie Petersdorf; Ann Woolfrey; David G Maloney; Brenda M Sandmaier
Low-dose total body irradiation and fludarabine conditioning for HLA class I-mismatched donor stem cell transplantation and immunologic recovery in patients with hematologic malignancies: a multicenter trial.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(3):384-94.
2010: Marcello Rotta; Barry E Storer; Rainer F Storb; Paul J Martin; Shelly Heimfeld; Amanda Peffer; David G Maloney; H Joachim Deeg; Brenda M Sandmaier; Frederick R Appelbaum; Marco Mielcarek
Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.
Blood 2010;115(6):1288-95.
2009: Boglarka Gyurkocza; Thai M Cao; Rainer F Storb; Thoralf Lange; Wendy Leisenring; Georg N Franke; Mohamed L Sorror; Richard Hoppe; David G Maloney; Robert S Negrin; Judith A Shizuru; Brenda M Sandmaier
Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1314-22.
2009: Hirohisa Nakamae; Katharine A Kirby; Brenda M Sandmaier; Lalita Norasetthada; David G Maloney; Michael B Maris; Chris Davis; Lawrence Corey; Rainer Storb; Michael Boeckh
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):694-703.
2009: Frédéric Baron; Effie W Petersdorf; Ted Gooley; Brenda M Sandmaier; Mari Malkki; Thomas R Chauncey; David G Maloney; Rainer Storb
What is the role for donor natural killer cells after nonmyeloablative conditioning?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(5):580-8.
2009: Marcello Rotta; Barry E Storer; Firoozeh Sahebi; Judith A Shizuru; Benedetto Bruno; Thoralf Lange; Edward D Agura; Peter A McSweeney; Michael Allen Pulsipher; Parameswaran Hari; Richard T Maziarz; Thomas R Chauncey; Frederick R Appelbaum; Mohamed L Sorror; William I Bensinger; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
2008: Jan Storek; Zhao Zhao; Yiping Liu; Richard Nash; Peter McSweeney; David G Maloney
Early recovery of CD4 T cell receptor diversity after "lymphoablative" conditioning and autologous CD34 cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(12):1373-9.
2008: Lauri M Burroughs; Paul V O'Donnell; Brenda M Sandmaier; Barry E Storer; Leo Luznik; HEATHER SYMONS; Richard J Jones; Richard F Ambinder; Michael B Maris; Karl G Blume; Dietger Niederwieser; Benedetto Bruno; Richard T Maziarz; Michael Allen Pulsipher; Finn B Petersen; Rainer Storb; Ephraim J Fuchs; David G Maloney
Comparison of outcomes of HLA-matched related, unrelated, or HLA-haploidentical related hematopoietic cell transplantation following nonmyeloablative conditioning for relapsed or refractory Hodgkin lymphoma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1279-87.
2008: Andrew R Rezvani; Lalitha Norasetthada; Ted Gooley; Mohamed Sorror; Michelle E Bouvier; Firoozeh Sahebi; Edward Agura; Thomas R Chauncey; Richard T Maziarz; Michael Maris; Judith Shizuru; Benedetto Bruno; Christopher Bredeson; Thoralf Lange; Andrew Yeager; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Non-myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: a multicentre experience.
British journal of haematology 2008;143(3):395-403.
2008: Mohamed L Sorror; Barry E Storer; Brenda M Sandmaier; Michael B Maris; Judith A Shizuru; Richard T Maziarz; Edward Agura; Thomas R Chauncey; Michael Allen Pulsipher; Peter A McSweeney; James C Wade; Benedetto Bruno; Amelia A Langston; Jerald P Radich; Dietger Niederwieser; Karl G Blume; Rainer Storb; David G Maloney
Five-year follow-up of patients with advanced chronic lymphocytic leukemia treated with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4912-20.
2008: Ajay K Gopal; Tracee L Metcalfe; Theodore A Gooley; John M Pagel; Stephen H Petersdorf; William I Bensinger; Leona Holmberg; David G Maloney; Oliver W Press
High-dose therapy and autologous stem cell transplantation for chemoresistant Hodgkin lymphoma: the Seattle experience.
Cancer 2008;113(6):1344-50.
2008: Ajay K Gopal; Oliver W Press; Shani M Wilbur; David G Maloney; John M Pagel
Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
Blood 2008;112(3):830-5.
2008: Brian G Till; Theodore A Gooley; Nathan Crawford; Ajay K Gopal; David G Maloney; Stephen H Petersdorf; John M Pagel; Leona Holmberg; William I Bensinger; Oliver W Press
Effect of remission status and induction chemotherapy regimen on outcome of autologous stem cell transplantation for mantle cell lymphoma.
Leukemia & lymphoma 2008;49(6):1062-73.
2008: Mohamed Sorror; Barry Storer; Brenda M Sandmaier; David G Maloney; Thomas R Chauncey; Amelia Langston; Richard T Maziarz; Michael Allen Pulsipher; Peter A McSweeney; Rainer Storb
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation.
Cancer 2008;112(9):1992-2001.
2008: Ginna G Laport; Brenda M Sandmaier; Barry E Storer; Bart L Scott; Monic J Stuart; Thoralf Lange; Michael B Maris; Edward D Agura; Thomas R Chauncey; Ruby M Wong; Stephen J Forman; Finn B Petersen; James C Wade; Elliot M Epner; Benedetto Bruno; Wolfgang A Bethge; Peter T Curtin; David G Maloney; Karl G Blume; Rainer F Storb
Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(2):246-55.
2008: Andrew R Rezvani; Barry Storer; Michael B Maris; Mohamed L Sorror; Edward Agura; Richard T Maziarz; James C Wade; Thomas R Chauncey; Stephen J Forman; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Brenda M Sandmaier; Rainer Storb; David G Maloney
Nonmyeloablative allogeneic hematopoietic cell transplantation in relapsed, refractory, and transformed indolent non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):211-7.
2008: David G Maloney
What is the role of maintenance rituximab in follicular NHL?
Oncology (Williston Park, N.Y.) 2008;22(1):20-6; discussion 26, 29, 33-4.
2008: Mohamed L Sorror; Barry E Storer; David G Maloney; Brenda M Sandmaier; Paul J Martin; Rainer Storb
Outcomes after allogeneic hematopoietic cell transplantation with nonmyeloablative or myeloablative conditioning regimens for treatment of lymphoma and chronic lymphocytic leukemia.
Blood 2008;111(1):446-52.
2007: Mohamed L Sorror; Sergio Giralt; Brenda M Sandmaier; Marcos De Lima; Munir Shahjahan; David G Maloney; H Joachim Deeg; Frederick R Appelbaum; Barry Storer; Rainer Storb
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
Blood 2007;110(13):4606-13.
2007: Marco Mielcarek; Barry E Storer; Brenda M Sandmaier; Mohamed L Sorror; David G Maloney; Effie W Petersdorf; Paul J Martin; Rainer Storb
Comparable outcomes after nonmyeloablative hematopoietic cell transplantation with unrelated and related donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(12):1499-507.
2007: R N Pham; Theodore A Gooley; G E Keeney; Oliver W Press; John M Pagel; H A Greisman; William I Bensinger; Leona A Holmberg; Stephen H Petersdorf; David G Maloney; Ajay K Gopal
The impact of histologic grade on the outcome of high-dose therapy and autologous stem cell transplantation for follicular lymphoma.
Bone marrow transplantation 2007;40(11):1039-44.
2007: Grant E Keeney; Theodore A Gooley; Rosalyn N Pham; Oliver W Press; John M Pagel; Stephen H Petersdorf; David G Maloney; William I Bensinger; Leona A Holmberg; Ajay K Gopal
The pretransplant Follicular Lymphoma International Prognostic Index is associated with survival of follicular lymphoma patients undergoing autologous hematopoietic stem cell transplantation.
Leukemia & lymphoma 2007;48(10):1961-7.
2007: Christoph Kahl; Barry E Storer; Brenda M Sandmaier; Marco Mielcarek; Michael B Maris; Karl G Blume; Dietger Niederwieser; Thomas R Chauncey; Stephen J Forman; Edward Agura; Jose F Leis; Benedetto Bruno; Amelia A Langston; Michael Allen Pulsipher; Peter A McSweeney; James C Wade; Elliot M Epner; Finn Bo Petersen; Wolfgang A Bethge; David G Maloney; Rainer Storb
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2007;110(7):2744-8.
2007: Mohamed L Sorror; Brenda M Sandmaier; Barry E Storer; Michael B Maris; Frédéric Baron; David G Maloney; Bart L Scott; H Joachim Deeg; Frederick R Appelbaum; Rainer Storb
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
2007: Frédéric Baron; Brenda M Sandmaier; Barry E Storer; Michael B Maris; Amelia A Langston; Thoralf Lange; Effie W Petersdorf; Wolfgang A Bethge; Richard T Maziarz; Peter A McSweeney; Michael Allen Pulsipher; James C Wade; Thomas R Chauncey; Judith A Shizuru; Mohamed L Sorror; Ann Woolfrey; David G Maloney; Rainer Storb
Extended mycophenolate mofetil and shortened cyclosporine failed to reduce graft-versus-host disease after unrelated hematopoietic cell transplantation with nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(9):1041-8.
2007: Ajay K Gopal; Joseph G Rajendran; Theodore A Gooley; John M Pagel; Darrell R Fisher; Stephen H Petersdorf; David G Maloney; Janet F Eary; Frederick R Appelbaum; Oliver W Press
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1396-402.
2007: George E Georges; Michael B Maris; David G Maloney; Brenda M Sandmaier; Mohamed L Sorror; Judith A Shizuru; Thoralf Lange; Edward D Agura; Benedetto Bruno; Peter A McSweeney; Michael Allen Pulsipher; Thomas R Chauncey; Marco Mielcarek; Barry E Storer; Rainer Storb
Nonmyeloablative unrelated donor hematopoietic cell transplantation to treat patients with poor-risk, relapsed, or refractory multiple myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(4):423-32.
2006: Frédéric Baron; Barry Storer; Michael B Maris; Jan Storek; Fanny Piette; Monja Metcalf; Kristen White; Brenda M Sandmaier; David G Maloney; Rainer Storb; Michael Boeckh
Unrelated donor status and high donor age independently affect immunologic recovery after nonmyeloablative conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1176-87.
2006: Oliver W Press; Joseph M Unger; Rita M Braziel; David G Maloney; Thomas P Miller; Michael LeBlanc; Richard I Fisher
Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4143-9.
2006: Frédéric Baron; Rainer Storb; Barry E Storer; Michael B Maris; Dietger Niederwieser; Judith A Shizuru; Thomas R Chauncey; Benedetto Bruno; Stephen J Forman; Peter A McSweeney; Richard T Maziarz; Michael Allen Pulsipher; Edward D Agura; James Wade; Mohamed L Sorror; David G Maloney; Brenda M Sandmaier
Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4150-7.
2006: Ajay K Gopal; John M Pagel; Joseph G Rajendran; David G Maloney; Frederick R Appelbaum; Mohamed L Sorror; Brenda M Sandmaier; Rainer Storb; Oliver W Press
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):697-702.
2006: Kathy Lilleby; P Garcia; Ted Gooley; P McDonnnell; R Taber; Leona A Holmberg; David G Maloney; Oliver W Press; William I Bensinger
A prospective, randomized study of cryotherapy during administration of high-dose melphalan to decrease the severity and duration of oral mucositis in patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2006;37(11):1031-5.
2006: Michael B Maris; Brenda M Sandmaier; Barry E Storer; David G Maloney; Judith A Shizuru; Edward Agura; Constanze Kliem; Michael Allen Pulsipher; Richard T Maziarz; Peter A McSweeney; James Wade; Amelia A Langston; Thomas R Chauncey; Benedetto Bruno; Karl G Blume; Rainer Storb
Unrelated donor granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell transplantation after nonmyeloablative conditioning: the effect of postgrafting mycophenolate mofetil dosing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(4):454-65.
2006: Lauri Burroughs; Marco Mielcarek; Wendy Leisenring; Brenda M Sandmaier; David G Maloney; Frédéric Baron; Paul J Martin; Mary E D Flowers; Stephen J Forman; Thomas R Chauncey; Benedetto Bruno; Rainer Storb
Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
Transplantation 2006;81(6):818-25.
2006: Bart L Scott; Brenda M Sandmaier; Barry Storer; Michael B Maris; Mohamed L Sorror; David G Maloney; Thomas R Chauncey; Rainer Storb; H Joachim Deeg
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Leukemia 2006;20(1):128-35.
2006: Renata E Zaucha; Dean C Buckner; Todd Barnett; Leona A Holmberg; Ted Gooley; Heather A Hooper; David G Maloney; Frederick R Appelbaum; William I Bensinger
Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.
International journal of radiation oncology, biology, physics 2006;64(1):227-34.
2005: Mohamed L Sorror; Michael B Maris; Rainer Storb; Frédéric Baron; Brenda M Sandmaier; David G Maloney; Barry Storer
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.
Blood 2005;106(8):2912-9.
2005: David G Maloney
Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(26):6421-8.
2005: Mohamed L Sorror; Michael B Maris; Brenda M Sandmaier; Barry E Storer; Monic J Stuart; Ute Hegenbart; Edward Agura; Thomas R Chauncey; Jose Leis; Michael Allen Pulsipher; Peter McSweeney; Jerald P Radich; Christopher N Bredeson; Benedetto Bruno; Amelia A Langston; Michael R Loken; Haifa-Kathrin Al-Ali; Karl G Blume; Rainer Storb; David G Maloney
Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(16):3819-29.
2005: Fabio R Kerbauy; Rainer Storb; Ute Hegenbart; Ted Gooley; Judith A Shizuru; Haifa-Kathrin Al-Ali; Jerald P Radich; David G Maloney; Edward Agura; Benedetto Bruno; Elliot M Epner; Thomas R Chauncey; Karl G Blume; Dietger Niederwieser; Brenda M Sandmaier
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Leukemia 2005;19(6):990-7.
2005: Marco Mielcarek; Lauri Burroughs; Wendy Leisenring; Razvan Diaconescu; Paul J Martin; Brenda M Sandmaier; David G Maloney; Michael B Maris; Thomas R Chauncey; Judith A Shizuru; Karl G Blume; Ute Hegenbart; Dietger Niederwieser; Stephen Forman; Benedetto Bruno; Ann Woolfrey; Rainer Storb
Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.
British journal of haematology 2005;129(3):381-91.
2005: Frédéric Baron; Michael B Maris; Barry E Storer; Brenda M Sandmaier; Jens P Panse; Thomas R Chauncey; Mohamed L Sorror; Marie-Térèse Little; David G Maloney; Rainer Storb; Shelly Heimfeld
High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation.
Leukemia 2005;19(5):822-8.
2005: Jason W Chien; Michael B Maris; Brenda M Sandmaier; David G Maloney; Rainer F Storb; Joan G Clark
Comparison of lung function after myeloablative and 2 Gy of total body irradiation-based regimens for hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):288-96.
2005: Frédéric Baron; Michael B Maris; Barry E Storer; Brenda M Sandmaier; Monic J Stuart; Peter A McSweeney; Jerald P Radich; Michael Allen Pulsipher; Edward D Agura; Thomas R Chauncey; David G Maloney; Judith A Shizuru; Rainer Storb
HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(4):272-9.
2005: Frédéric Baron; Michael B Maris; Brenda M Sandmaier; Barry E Storer; Mohamed L Sorror; Razvan Diaconescu; Ann Woolfrey; Thomas R Chauncey; Mary E D Flowers; Marco Mielcarek; David G Maloney; Rainer Storb
Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(9):1993-2003.
2005: Tomas Kalina; Hailing Lu; Zhao Zhao; Earl Blewett; Dirk P Dittmer; Julie Randolph-Habecker; David G Maloney; Robert G Andrews; Hans-Peter Kiem; Jan Storek
De novo generation of CD4 T cells against viruses present in the host during immune reconstitution.
Blood 2005;105(6):2410-4.
2005: chirag parikh; Robert W Schrier; Barry Storer; Razvan Diaconescu; Mohamed L Sorror; Michael B Maris; David G Maloney; Peter McSweeney; Rainer Storb; Brenda M Sandmaier
Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(3):502-9.
2005: Jens P Panse; Shelly Heimfeld; Katherine A Guthrie; Michael B Maris; David G Maloney; B B Baril; Marie-Térèse Little; Thomas R Chauncey; Barry E Storer; Rainer Storb; Brenda M Sandmaier
Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning.
British journal of haematology 2005;128(5):659-67.
2005: David G Maloney
Concepts in radiotherapy and immunotherapy: anti-CD20 mechanisms of action and targets.
Seminars in oncology 2005;32(1 Suppl 1):S19-26.
2005: David G Maloney
Treatment of follicular non-Hodgkin's lymphoma.
Current hematology reports 2005;4(1):39-45.
2005: Hailing Lu; Zhao Zhao; Tomas Kalina; Thurman Gillespy; Denny Liggitt; Robert G Andrews; David G Maloney; Hans-Peter Kiem; Jan Storek
Interleukin-7 improves reconstitution of antiviral CD4 T cells.
Clinical immunology (Orlando, Fla.) 2005;114(1):30-41.
2004: Jan Storek; Zhao Zhao; Eugene Lin; Thomas Berger; Peter A McSweeney; Richard A Nash; Yoshiki Akatsuka; Monja D Metcalf; Hailing Lu; Tomas Kalina; Markus Reindl; Rainer Storb; John A Hansen; Keith M Sullivan; George H Kraft; Daniel E Furst; David G Maloney
Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases).
Clinical immunology (Orlando, Fla.) 2004;113(3):285-98.
2004: Michael B Maris; Brenda M Sandmaier; Barry E Storer; Thomas R Chauncey; Monic J Stuart; Richard T Maziarz; Edward Agura; Amelia A Langston; Michael Allen Pulsipher; Rainer Storb; David G Maloney
Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma.
Blood 2004;104(12):3535-42.
2004: Frédéric Baron; Jennifer E Baker; Rainer Storb; Theodore A Gooley; Brenda M Sandmaier; Michael B Maris; David G Maloney; Shelly Heimfeld; Dmitrij Oparin; Eustacia Zellmer; Jerald P Radich; F Carl Grumet; Karl G Blume; Thomas R Chauncey; Marie-Térèse Little
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.
Blood 2004;104(8):2254-62.
2004: Razvan Diaconescu; Christopher R Flowers; Barry Storer; Mohamed L Sorror; Michael B Maris; David G Maloney; Brenda M Sandmaier; Rainer Storb
Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.
Blood 2004;104(5):1550-8.
2004: Mohamed L Sorror; Michael B Maris; Barry Storer; Brenda M Sandmaier; Razvan Diaconescu; Christopher R Flowers; David G Maloney; Rainer Storb
Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities.
Blood 2004;104(4):961-8.
2004: chirag parikh; Brenda M Sandmaier; Rainer F Storb; Karl G Blume; Firoozeh Sahebi; David G Maloney; Michael B Maris; Yago Nieto; Charles L Edelstein; Robert W Schrier; Peter McSweeney
Acute renal failure after nonmyeloablative hematopoietic cell transplantation.
Journal of the American Society of Nephrology : JASN 2004;15(7):1868-76.
2004: Jan Storek; Monja A Dawson; L C-L Lim; B E Burman; Terry Stevens-Ayers; Federico Viganego; M M P T Herremans; Mary E D Flowers; Robert P Witherspoon; David G Maloney; Michael Boeckh
Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation.
Bone marrow transplantation 2004;33(3):337-46.
2004: Wolfgang A Bethge; Ute Hegenbart; Monic J Stuart; Barry E Storer; Michael B Maris; Mary E D Flowers; David G Maloney; Thomas R Chauncey; Benedetto Bruno; Edward Agura; Stephen J Forman; Karl G Blume; Dietger Niederwieser; Rainer Storb; Brenda M Sandmaier
Adoptive immunotherapy with donor lymphocyte infusions after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning.
Blood 2004;103(3):790-5.
2004: William J Hogan; Michael B Maris; Barry Storer; Brenda M Sandmaier; David G Maloney; H Gary Schoch; Ann Woolfrey; Howard M Shulman; Rainer Storb; George B McDonald
Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients.
Blood 2004;103(1):78-84.
2003: Jan Storek; Monja A Dawson; David G Maloney
Correlation between the numbers of naive T cells infused with blood stem cell allografts and the counts of naive T cells after transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(12):781-4.
2003: Christian Junghanss; Rainer Storb; Michael B Maris; Rachel A Carter; Brenda M Sandmaier; David G Maloney; Peter A McSweeney; Lawrence Corey; Michael Boeckh
Impact of unrelated donor status on the incidence and outcome of cytomegalovirus infections after non-myeloablative allogeneic stem cell transplantation.
British journal of haematology 2003;123(4):662-70.
2003: David G Maloney; Arthur J Molina; Firoozeh Sahebi; Keith E Stockerl-Goldstein; Brenda M Sandmaier; William I Bensinger; Barry Storer; Ute Hegenbart; George Somlo; Thomas R Chauncey; Benedetto Bruno; Frederick R Appelbaum; Karl G Blume; Stephen J Forman; Peter McSweeney; Rainer Storb
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Blood 2003;102(9):3447-54.
2003: Wolfgang A Bethge; Barry E Storer; Michael B Maris; Mary E D Flowers; David G Maloney; Thomas R Chauncey; Ann Woolfrey; Rainer Storb; Brenda M Sandmaier
Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome.
Experimental hematology 2003;31(10):974-80.
2003: Ajay K Gopal; Theodore A Gooley; David G Maloney; Stephen H Petersdorf; Janet F Eary; Joseph G Rajendran; Sharon A Bush; Lawrence D Durack; Jane Golden; Paul J Martin; Dana C Matthews; Frederick R Appelbaum; Irwin D Bernstein; Oliver W Press
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.
Blood 2003;102(7):2351-7.
2003: Oliver W Press; Joseph M Unger; Rita M Braziel; David G Maloney; Thomas P Miller; Michael LeBlanc; Ellen R Gaynor; Saul E Rivkin; Richard I Fisher
A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911.
Blood 2003;102(5):1606-12.
2003: Takahiro Fukuda; Michael Boeckh; Rachel A Carter; Brenda M Sandmaier; Michael B Maris; David G Maloney; Paul J Martin; Rainer F Storb; Kieren Marr
Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning.
Blood 2003;102(3):827-33.
2003: Marco Mielcarek; Paul J Martin; Wendy Leisenring; Mary E D Flowers; David G Maloney; Brenda M Sandmaier; Michael B Maris; Rainer Storb
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.
Blood 2003;102(2):756-62.
2003: Jan Storek; Thurman Gillespy; Hailing Lu; Ansamma Joseph; Monja A Dawson; Mike Gough; Julia Morris; Robert C Hackman; Peter A Horn; George E Sale; Robert G Andrews; David G Maloney; Hans-Peter Kiem
Interleukin-7 improves CD4 T-cell reconstitution after autologous CD34 cell transplantation in monkeys.
Blood 2003;101(10):4209-18.
2003: Jan Storek; Federico Viganego; Monja A Dawson; M M P Tineke Herremans; Michael Boeckh; Mary E D Flowers; Barry Storer; William I Bensinger; Robert P Witherspoon; David G Maloney
Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.
Blood 2003;101(8):3319-24.
2003: Lyle Feinstein; Brenda M Sandmaier; David G Maloney; Michael B Maris; Theodore A Gooley; Thomas R Chauncey; Ute Hegenbart; Peter A McSweeney; Monic J Stuart; Stephen J Forman; Edward Agura; Michael Allen Pulsipher; Karl G Blume; Dietger Niederwieser; Rainer F Storb
Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(4):266-72.
2003: David G Maloney
Graft-vs.-lymphoma effect in various histologies of non-Hodgkin's lymphoma.
Leukemia & lymphoma 2003;44 Suppl 3():S99-105.
2003: David G Maloney
Rituximab for follicular lymphoma.
Current hematology reports 2003;2(1):13-22.
2003: Lyle Feinstein; Brenda M Sandmaier; Ute Hegenbart; Peter A McSweeney; David G Maloney; Theodore A Gooley; Michael B Maris; Thomas R Chauncey; Benedetto Bruno; Frederick R Appelbaum; Dietger Niederwieser; Rainer F Storb
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
British journal of haematology 2003;120(2):281-8.
2002: J Maciej Zaucha; Marco Mielcarek; Alessandra Takatu; Marie-Térèse Little; Ted Gooley; Jennifer Baker; David G Maloney; Brenda M Sandmaier; Michael B Maris; Thomas R Chauncey; Rainer Storb; Beverly Torok-Storb
Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):740-50.
2002: Andrea L Rose; Barbara E Smith; David G Maloney
Glucocorticoids and rituximab in vitro: synergistic direct antiproliferative and apoptotic effects.
Blood 2002;100(5):1765-73.
2002: Ajay K Gopal; Joseph G Rajendran; Stephen H Petersdorf; David G Maloney; Janet F Eary; Brent L Wood; Theodore A Gooley; Sharon A Bush; Lawrence D Durack; Paul J Martin; Dana C Matthews; Frederick R Appelbaum; Irwin D Bernstein; Oliver W Press
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.
Blood 2002;99(9):3158-62.
2002: Jan Storek; Ansamma Joseph; Monja A Dawson; Daniel C Douek; Barry Storer; David G Maloney
Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation.
Transplantation 2002;73(7):1154-8.
2002: Christian Junghanss; Michael Boeckh; Rachel A Carter; Brenda M Sandmaier; Michael B Maris; David G Maloney; Thomas R Chauncey; Peter A McSweeney; Marie-Térèse Little; Lawrence Corey; Rainer Storb
Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.
Blood 2002;99(6):1978-85.
2002: Marco Mielcarek; Brenda M Sandmaier; David G Maloney; Michael B Maris; Peter A McSweeney; Ann Woolfrey; Thomas R Chauncey; Lyle Feinstein; Dietger Niederwieser; Karl G Blume; Stephen Forman; Beverly Torok-Storb; Rainer Storb
Nonmyeloablative hematopoietic cell transplantation: status quo and future perspectives.
Journal of clinical immunology 2002;22(2):70-4.
2002: Jan Storek; Bojan B Lalovic; Kate Rupert; Monja A Dawson; Danny D Shen; David G Maloney
Kinetics of B, CD4 T, and CD8 T cells infused into humans: estimates of intravascular:extravascular ratios and total body counts.
Clinical immunology (Orlando, Fla.) 2002;102(3):249-57.
2002: David G Maloney; Barbara Smith; Andrea Rose
Rituximab: mechanism of action and resistance.
Seminars in oncology 2002;29(1 Suppl 2):2-9.
2002: Michael L Linenberger; David G Maloney; Irwin D Bernstein
Antibody-directed therapies for hematological malignancies.
Trends in molecular medicine 2002;8(2):69-76.
2002: David G Maloney; Brenda M Sandmaier; Stephen Mackinnon; Judith A Shizuru
Non-myeloablative transplantation.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():392-421.
2002: Christian Junghanss; Kieren Marr; Rachel A Carter; Brenda M Sandmaier; Michael B Maris; David G Maloney; Thomas R Chauncey; Peter A McSweeney; Rainer Storb
Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(9):512-20.
2001: F Weissinger; Brenda M Sandmaier; David G Maloney; William I Bensinger; Ted Gooley; Rainer Storb
Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.
Blood 2001;98(13):3584-8.
2001: Jan Storek; Ansamma Joseph; German Espino; Monja A Dawson; D C Douek; Keith M Sullivan; Mary E D Flowers; P Martin; G Mathioudakis; Richard A Nash; Rainer Storb; Frederick R Appelbaum; David G Maloney
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
Blood 2001;98(13):3505-12.
2001: F Gutierrez-Delgado; David G Maloney; Oliver W Press; J Golden; Leona A Holmberg; Richard T Maziarz; Heather A Hooper; C Dean Buckner; Frederick R Appelbaum; William I Bensinger
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.
Bone marrow transplantation 2001;28(5):455-61.
2001: Michael B Maris; Ann Woolfrey; Peter A McSweeney; Brenda M Sandmaier; Richard A Nash; George E Georges; David G Maloney; A Molina; Thomas R Chauncey; Cong Yu; Jan M Zaucha; Karl G Blume; Judith A Shizuru; Dietger Niederwieser; Rainer Storb
Nonmyeloablative hematopoietic stem cell transplantation: transplantation for the 21st century.
Frontiers in bioscience : a journal and virtual library 2001;6():G13-6.
2001: Jan Storek; D Wells; Monja A Dawson; Barry Storer; David G Maloney
Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation.
Blood 2001;98(2):489-91.
2001: Michael B Maris; Brenda M Sandmaier; David G Maloney; Peter A McSweeney; Ann Woolfrey; Thomas R Chauncey; Judith A Shizuru; Dietger Niederwieser; Karl G Blume; Stephen Forman; Rainer Storb
Non-myeloablative hematopoietic stem cell transplantation.
Transfusion clinique et biologique : journal de la Société française de transfusion sanguine 2001;8(3):231-4.
2001: Peter A McSweeney; Dietger Niederwieser; Judith A Shizuru; Brenda M Sandmaier; A J Molina; David G Maloney; Thomas R Chauncey; Theodore A Gooley; Ute Hegenbart; Richard A Nash; Jerald P Radich; JL Wagner; S Minor; Frederick R Appelbaum; William I Bensinger; Eileen Bryant; Mary E D Flowers; George E Georges; F Carl Grumet; Hans-Peter Kiem; Beverly Torok-Storb; Cong Yu; Karl G Blume; Rainer Storb
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
2001: Jan Storek; Monja A Dawson; Barry Storer; Terry Stevens-Ayers; David G Maloney; Kieren Marr; Robert P Witherspoon; William I Bensinger; Mary E D Flowers; P Martin; Rainer Storb; Frederick R Appelbaum; Michael Boeckh
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Blood 2001;97(11):3380-9.
2001: Ajay K Gopal; Theodore A Gooley; J B Golden; David G Maloney; William I Bensinger; Stephen H Petersdorf; Frederick R Appelbaum; Oliver W Press
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.
Bone marrow transplantation 2001;27(6):593-9.
2000: Rainer Storb; Peter A McSweeney; Brenda M Sandmaier; Richard A Nash; George E Georges; David G Maloney; A Molina; Thomas R Chauncey; Cong Yu; Jan M Zaucha; Karl G Blume; Judith A Shizuru; Dietger Niederwieser
Allogeneic hematopoietic stem cell transplantation: from the nuclear age into the twenty-first century.
Transplantation proceedings 2000;32(7):2548-9.
2000: Jan Storek; German Espino; Monja A Dawson; Barry Storer; Mary E D Flowers; David G Maloney
Low B-cell and monocyte counts on day 80 are associated with high infection rates between days 100 and 365 after allogeneic marrow transplantation.
Blood 2000;96(9):3290-3.
2000: Oliver W Press; Janet F Eary; Ted Gooley; Ajay K Gopal; S Liu; Joseph G Rajendran; David G Maloney; Stephen H Petersdorf; Sharon A Bush; Lawrence D Durack; Paul J Martin; Darrell R Fisher; Brent Wood; J W Borrow; B Porter; J P Smith; Dana C Matthews; Frederick R Appelbaum; Irwin D Bernstein
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.
Blood 2000;96(9):2934-42.
2000: Jan Storek; Monja A Dawson; David G Maloney
Normal T, B, and NK cell counts in healthy donors at 1 year after blood stem cell harvesting.
Blood 2000;95(9):2993-4.
1999: Leona A Holmberg; Michael Boeckh; Heather A Hooper; Wendy Leisenring; Scott D Rowley; Shelly Heimfeld; Oliver W Press; David G Maloney; Peter McSweeney; Lawrence Corey; Richard T Maziarz; Frederick R Appelbaum; William I Bensinger
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.
Blood 1999;94(12):4029-35.
1999: David G Maloney
Preclinical and phase I and II trials of rituximab.
Seminars in oncology 1999;26(5 Suppl 14):74-8.
1999: David G Maloney
Advances in the immunotherapy of hematologic malignancies: cellular and humoral approaches.
Current opinion in hematology 1999;6(4):222-8.
1999: David G Maloney; K Donovan; T J Hamblin
Antibody therapy for treatment of multiple myeloma.
Seminars in hematology 1999;36(1 Suppl 3):30-3.
1998: David G Maloney; Oliver W Press
Newer treatments for non-Hodgkin's lymphoma: monoclonal antibodies.
Oncology (Williston Park, N.Y.) 1998;12(10 Suppl 8):63-76.
1998: S Y Liu; Janet F Eary; Stephen H Petersdorf; Paul J Martin; David G Maloney; Frederick R Appelbaum; Dana C Matthews; Sharon A Bush; Lawrence D Durack; Darrell R Fisher; Theodore A Gooley; Irwin D Bernstein; Oliver W Press
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3270-8.
1998: Jan Storek; Monja A Dawson; David G Maloney
Comparison of two flow cytometric methods enumerating CD4 T cells and CD8 T cells.
Cytometry 1998;33(1):76-82.
1998: David G Maloney
Advances in immunotherapy of hematologic malignancies.
Current opinion in hematology 1998;5(4):237-43.
1997: K Schiffman; C Dean Buckner; Richard T Maziarz; David G Maloney; Frederick R Appelbaum; Oliver W Press; Ted Gooley; Leona A Holmberg; Kathy Lilleby; Reginald Clift; N Zuckerman; JP Klarnet; C Weaver; Thomas R Chauncey; William I Bensinger
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):261-6.
1996: William I Bensinger; Scott D Rowley; Taner Demirer; Kathy Lilleby; K Schiffman; Reginald Clift; Frederick R Appelbaum; Alexander Fefer; T Barnett; Rainer Storb; Thomas R Chauncey; Richard T Maziarz; J Klarnet; P McSweeney; Leona A Holmberg; David G Maloney; Charles H Weaver; C Dean Buckner
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
1995: David G Maloney
Non-Hodgkin's lymphoma.
Current opinion in hematology 1995;2(4):255-61.